Yukinori Sakao

Summary

Affiliation: Saga Medical School
Country: Japan

Publications

  1. ncbi request reprint Clinicopathological analysis of prognostic factors in clinical IA peripheral adenocarcinoma of the lung
    Yukinori Sakao
    Department of Thoracic and Cardiovascular Surgery, Saga Medical School, Saga, Japan
    Ann Thorac Surg 75:1113-7. 2003
  2. ncbi request reprint Lung adenocarcinoma can be subtyped according to tumor dimension by computed tomography mediastinal-window setting. Additional size criteria for clinical T1 adenocarcinoma
    Yukinori Sakao
    Department of Thoracic and Cardiovascular Surgery, Saga Medical School, Nabesima 5 1 1, Saga 849 8501, Japan
    Eur J Cardiothorac Surg 26:1211-5. 2004
  3. ncbi request reprint Predictive factors for survival in surgically resected clinical IA peripheral adenocarcinoma of the lung
    Yukinori Sakao
    Department of Thoracic and Cardiovascular Surgery, Saga Medical School of University, Nabesima, Saga, Japan
    Ann Thorac Surg 77:1157-61; discussion 1161-2. 2004
  4. ncbi request reprint Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma
    Yukinori Sakao
    Department of Thoracic and Cardiovascular Surgery, Saga Medical School of the University, Nabesima, 5 1 1, Saga 849 8501, Japan
    Eur J Cardiothorac Surg 25:520-2. 2004
  5. ncbi request reprint Lymph node metastasis, recurrence, and prognosis in small peripheral lung adenocarcinoma. Analysis based on replacement
    Tohru Sakuragi
    Department of Thoracic and Cardiovascular Surgery, Saga Medical School, 5 1 1 Nabeshima, Saga 849 8501, Japan
    Jpn J Thorac Cardiovasc Surg 50:424-9. 2002
  6. ncbi request reprint Hsp90 inhibitors cause G2/M arrest associated with the reduction of Cdc25C and Cdc2 in lung cancer cell lines
    Megumi Senju
    Department of Internal Medicine, Faculty of Medicine, Saga University, Saga 849 8501, Japan
    J Cancer Res Clin Oncol 132:150-8. 2006
  7. ncbi request reprint Successful management of acute pulmonary embolism after surgery for lung cancer
    Toru Sakuragi
    Department of Thoracic and Cardiovascular Surgery, Saga Medical School, 5 1 1 Nabeshima, Saga 849 8501, Japan
    Eur J Cardiothorac Surg 24:580-7. 2003
  8. ncbi request reprint Alteration of expression or phosphorylation status of tob, a novel tumor suppressor gene product, is an early event in lung cancer
    Kentaro Iwanaga
    Department of Internal Medicine, Saga Medical School, Saga 849 8501, Japan
    Cancer Lett 202:71-9. 2003
  9. ncbi request reprint Giant cell tumor of the rib
    Yukinori Sakao
    Department of Thoracic and Cardiovascular Surgery, Saga Medical School, Nabeshima 5 1 1, Saga City 849 8501, Japan
    Jpn J Thorac Cardiovasc Surg 51:537-40. 2003
  10. ncbi request reprint Malignant fibrous histiocytoma of the trachea
    Yukinori Sakao
    Department of Thoracic and Cardiovascular Surgery, Saga Medical School, Saga, Japan
    Jpn J Thorac Cardiovasc Surg 53:276-9. 2005

Collaborators

Detail Information

Publications21

  1. ncbi request reprint Clinicopathological analysis of prognostic factors in clinical IA peripheral adenocarcinoma of the lung
    Yukinori Sakao
    Department of Thoracic and Cardiovascular Surgery, Saga Medical School, Saga, Japan
    Ann Thorac Surg 75:1113-7. 2003
    ..We have tried to clarify the prognostic factors in C-IA adenocarcinoma of the lung to identify those candidates who might benefit from preoperative or postoperative adjuvant therapy...
  2. ncbi request reprint Lung adenocarcinoma can be subtyped according to tumor dimension by computed tomography mediastinal-window setting. Additional size criteria for clinical T1 adenocarcinoma
    Yukinori Sakao
    Department of Thoracic and Cardiovascular Surgery, Saga Medical School, Nabesima 5 1 1, Saga 849 8501, Japan
    Eur J Cardiothorac Surg 26:1211-5. 2004
    ..We sought to verify that the size of the solid component, which can be evaluated using the computed tomography mediastinal-window setting, provides new criteria for CT classification of lung adenocarcinoma...
  3. ncbi request reprint Predictive factors for survival in surgically resected clinical IA peripheral adenocarcinoma of the lung
    Yukinori Sakao
    Department of Thoracic and Cardiovascular Surgery, Saga Medical School of University, Nabesima, Saga, Japan
    Ann Thorac Surg 77:1157-61; discussion 1161-2. 2004
    ..We attempted to clarify preoperative factors that are predictive for poor prognosis after surgery among patients diagnosed with C-IA adenocarcinoma of the lung...
  4. ncbi request reprint Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma
    Yukinori Sakao
    Department of Thoracic and Cardiovascular Surgery, Saga Medical School of the University, Nabesima, 5 1 1, Saga 849 8501, Japan
    Eur J Cardiothorac Surg 25:520-2. 2004
    ..To clarify the usefulness of measuring serum carcinoembryonic antigen (CEA) preoperatively to detect patients who will have a poor outcome after surgery, and who cannot be selected by conventional staging modalities...
  5. ncbi request reprint Lymph node metastasis, recurrence, and prognosis in small peripheral lung adenocarcinoma. Analysis based on replacement
    Tohru Sakuragi
    Department of Thoracic and Cardiovascular Surgery, Saga Medical School, 5 1 1 Nabeshima, Saga 849 8501, Japan
    Jpn J Thorac Cardiovasc Surg 50:424-9. 2002
    ....
  6. ncbi request reprint Hsp90 inhibitors cause G2/M arrest associated with the reduction of Cdc25C and Cdc2 in lung cancer cell lines
    Megumi Senju
    Department of Internal Medicine, Faculty of Medicine, Saga University, Saga 849 8501, Japan
    J Cancer Res Clin Oncol 132:150-8. 2006
    ..We investigated whether Hsp90 inhibitors have therapeutic value in lung cancer...
  7. ncbi request reprint Successful management of acute pulmonary embolism after surgery for lung cancer
    Toru Sakuragi
    Department of Thoracic and Cardiovascular Surgery, Saga Medical School, 5 1 1 Nabeshima, Saga 849 8501, Japan
    Eur J Cardiothorac Surg 24:580-7. 2003
    ..This report describes seven cases of successful management of APE after surgery for lung cancer and discusses how to manage this problematic complication...
  8. ncbi request reprint Alteration of expression or phosphorylation status of tob, a novel tumor suppressor gene product, is an early event in lung cancer
    Kentaro Iwanaga
    Department of Internal Medicine, Saga Medical School, Saga 849 8501, Japan
    Cancer Lett 202:71-9. 2003
    ..The above findings suggest that the disruption of anti-proliferative Tob plays a distinct part in the early stage of lung carcinogenesis...
  9. ncbi request reprint Giant cell tumor of the rib
    Yukinori Sakao
    Department of Thoracic and Cardiovascular Surgery, Saga Medical School, Nabeshima 5 1 1, Saga City 849 8501, Japan
    Jpn J Thorac Cardiovasc Surg 51:537-40. 2003
    ..The pathological diagnosis was a GCT. The patient remains well without evidence of recurrence for 6 years following surgery. The present case is only the 14th case of GCT arising in the rib to have been reported in Japan...
  10. ncbi request reprint Malignant fibrous histiocytoma of the trachea
    Yukinori Sakao
    Department of Thoracic and Cardiovascular Surgery, Saga Medical School, Saga, Japan
    Jpn J Thorac Cardiovasc Surg 53:276-9. 2005
    ..A radical excision of the tumor (tracheal resection) with tracheal plasty was performed. The microscopic diagnosis was MFH. The patient remains well, without evidence of recurrence, 3 months after surgery...
  11. ncbi request reprint Arterial embolization to preoperatively manage pulmonary disease associated with inflammation
    Tohru Sakuragi
    Department of Thoracic and Cardiovascular Surgery, Saga Medical School, 5 1 1 Nabeshima, Saga 849 8501, Japan
    Jpn J Thorac Cardiovasc Surg 50:125-8. 2002
    ..Such preoperative management proved useful in reducing intraoperative blood loss in hypervascular collateral feeding vessels in the area of resection or decortication...
  12. ncbi request reprint Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer
    Yukinori Sakao
    Department of General Thoracic Surgery, Juntendo University School of Medicine, Tokyo, Japan
    Ann Thorac Surg 81:292-7. 2006
    ..We have tried to clarify the prognostic significance of metastasis to the highest mediastinal (HM) lymph node in patients with N2 lung cancer who underwent complete dissection of superior mediastinal (including HM) lymph nodes...
  13. ncbi request reprint Clinicopathological factors associated with unexpected N3 in patients with mediastinal lymph node involvement
    Yukinori Sakao
    Department of General Thoracic Surgery, Juntendo University School of Medicine, Bunkyo ku, Tokyo, Japan
    J Thorac Oncol 2:1107-11. 2007
    ..In this retrospective study, we aimed to clarify the clinicopathological factors associated with p-N3 in patients with mediastinal lymph node involvement (excluding c-N3) who underwent ERD, and we studied their impact on prognosis...
  14. ncbi request reprint The spread of metastatic lymph nodes to the mediastinum from left upper lobe cancer: results of superior mediastinal nodal dissection through a median sternotomy
    Yukinori Sakao
    Department of General Thoracic Surgery, Juntendo University School of Medicine, 2 1 1 Hongo, Tokyo 113 8421, Japan
    Eur J Cardiothorac Surg 30:543-7. 2006
    ....
  15. ncbi request reprint Video-assisted thoracoscopic lobectomy vs. conventional lobectomy via open thoracotomy in patients with clinical stage IA non-small cell lung carcinoma
    Motoki Sakuraba
    Department of General Thoracic Surgery, Juntendo University, School of Medicine, Hongo 2 1 1 Bunkyo ku, Tokyo, 113 8421, Japan
    Interact Cardiovasc Thorac Surg 6:614-7. 2007
    ..We consider VATS lobectomy to be one of the therapeutic options in patients with clinical stage IA non-small cell lung carcinoma...
  16. ncbi request reprint Prognostic significance of a histologic subtype in small adenocarcinoma of the lung: the impact of nonbronchioloalveolar carcinoma components
    Yukinori Sakao
    Department of General Thoracic Surgery, Juntendo University School of Medicine, Bunkyo ku, Tokyo, Japan
    Ann Thorac Surg 83:209-14. 2007
    ....
  17. ncbi request reprint The prognostic value of carcinoembryonic antigen in T1N1M0 and T2N1M0 non-small cell carcinoma of the lung
    Ryuta Fukai
    Department of General Thoracic Surgery, Juntendo University School of Medicine, 2 1 1 Hongo, Bunkyo ku, Tokyo 113 8431, Japan
    Eur J Cardiothorac Surg 32:440-4. 2007
    ....
  18. ncbi request reprint Prospective analysis of depression and psychological distress before and after surgical resection of lung cancer
    Shiaki Oh
    Department of General Thoracic Surgery, Juntendo University, School of Medicine, 2 1 1 Hongo, Bunkyo ku, Tokyo, Japan
    Gen Thorac Cardiovasc Surg 55:119-24. 2007
    ..This study was done to assess the mental state of patients with lung cancer before and after surgery and to determine their need for psychological care...
  19. ncbi request reprint A case of aspergilloma detected after surgery for pneumothorax
    Motoki Sakuraba
    Department of General Thoracic Surgery, Juntendo University, School of Medicine, Tokyo, Japan
    Ann Thorac Cardiovasc Surg 12:267-9. 2006
    ..Aspergillus was detected histopathologically in the nodule. Treatment with itraconazole 200 mg a day followed, and 4 months later he had no recurrent pneumothorax or Aspergillus infection...
  20. ncbi request reprint Novel ELISA system for detection of N-ERC/mesothelin in the sera of mesothelioma patients
    Kazu Shiomi
    Department of General Thoracic Surgery, Respiratory Medicine, Juntendo University, School of Medicine, 2 1 1 Hongo, Tokyo 113 8421, Japan
    Cancer Sci 97:928-32. 2006
    ..In conclusion, N-ERC/mesothelin is a promising candidate tumor marker for mesothelioma...
  21. doi request reprint Sensitive and specific new enzyme-linked immunosorbent assay for N-ERC/mesothelin increases its potential as a useful serum tumor marker for mesothelioma
    Kazu Shiomi
    Department of General Thoracic Surgery, Respiratory Medicine, Human Pathology, Juntendo University, School of Medicine, Tokyo, Japan
    Clin Cancer Res 14:1431-7. 2008
    ..It would be very useful to identify a tumor marker that could be used for screening to enable more diagnoses to be made at an early, treatable stage...